• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DT-13 通过肿瘤微环境同步适应中的非肌肉肌球蛋白 II-A 调控抑制乳腺癌细胞迁移。

DT-13 inhibits breast cancer cell migration via non-muscle myosin II-A regulation in tumor microenvironment synchronized adaptations.

机构信息

Jiangsu Center for Drug Screening, China Pharmaceutical University, Nanjing, 210009, China.

State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, People's Republic of China.

出版信息

Clin Transl Oncol. 2020 Sep;22(9):1591-1602. doi: 10.1007/s12094-020-02303-z. Epub 2020 Feb 13.

DOI:10.1007/s12094-020-02303-z
PMID:32056128
Abstract

BACKGROUND

Tumor metastasis is a terrifying characteristic of cancer. Numerous studies have been conducted to overcome metastasis by targeting tumor microenvironment (TME). However, due to complexity of tumor microenvironment, it remained difficult for accurate targeting. Dwarf-lillytruf tuber monomer-13 (DT-13) possess good potential against TME.

OBJECTIVE

As TME is supportive for tumor metastasis, alternatively it is a challenging for therapeutic intervention. In our present study, we explored molecular mechanism through which TME induced cell migration and how DT-13 interferes in this mechanism.

METHODS

We used a novel model of co-culture system which is eventually developed in our lab. Tumor cells were co-cultured with hypoxia induced cancer-associated fibroblasts (CAF) or with chemically induced cancer-associated adipocytes (CAA). The effect of hypoxia in conditioned medium for CAF was assessed through expression of α-SMA and HIF by western blotting while oil red staining was done to assess the successful chemical induction for adipocytes (CAA), the effect of TME through conditioned medium on cell migration was analyzed by trans-well cell migration, and cell motility (wound healing) analyses. The expression changes in cellular proteins were assessed through western blotting and immunofluorescent studies.

RESULTS AND CONCLUSION

Our results showed that tumor microenvironment has a direct role in promoting breast cancer cell migration by stromal cells; moreover, we found that DT-13 restricts this TME regulated cell migration via targeting stromal cells in vitro. Additionally we also found that DT-13 targets NMII-A for its effect on breast cancer cell migration for the regulation of stromal cells in TME.

摘要

背景

肿瘤转移是癌症的一个可怕特征。为了克服肿瘤微环境(TME)的影响,已经进行了许多研究。然而,由于肿瘤微环境的复杂性,对其进行准确靶向仍然很困难。矮百合菝葜单体-13(DT-13)对 TME 具有很好的靶向潜力。

目的

由于 TME 支持肿瘤转移,因此对其进行治疗干预具有挑战性。在本研究中,我们探讨了 TME 诱导细胞迁移的分子机制,以及 DT-13 如何干扰这一机制。

方法

我们使用了一种新型共培养系统模型,该模型最终由我们实验室开发。将肿瘤细胞与缺氧诱导的癌症相关成纤维细胞(CAF)或化学诱导的癌症相关脂肪细胞(CAA)共培养。通过 Western blot 检测 CAF 条件培养基中 α-SMA 和 HIF 的表达,评估缺氧对 CAF 的影响;通过 Transwell 细胞迁移和细胞迁移(划痕愈合)分析,评估 TME 通过条件培养基对细胞迁移的影响;通过 Western blot 和免疫荧光研究评估细胞蛋白表达变化。

结果与结论

结果表明,肿瘤微环境通过基质细胞直接促进乳腺癌细胞迁移;此外,研究发现 DT-13 通过靶向体外 TME 调节的细胞迁移中的基质细胞来限制这种 TME 调节的细胞迁移。此外,研究还发现 DT-13 通过靶向 NMII-A 来调节 TME 中的基质细胞,从而影响乳腺癌细胞迁移。

相似文献

1
DT-13 inhibits breast cancer cell migration via non-muscle myosin II-A regulation in tumor microenvironment synchronized adaptations.DT-13 通过肿瘤微环境同步适应中的非肌肉肌球蛋白 II-A 调控抑制乳腺癌细胞迁移。
Clin Transl Oncol. 2020 Sep;22(9):1591-1602. doi: 10.1007/s12094-020-02303-z. Epub 2020 Feb 13.
2
DT-13 inhibits cancer cell migration by regulating NMIIA indirectly in the tumor microenvironment.DT-13通过在肿瘤微环境中间接调节肌球蛋白重链IIA(NMIIA)来抑制癌细胞迁移。
Oncol Rep. 2016 Aug;36(2):721-8. doi: 10.3892/or.2016.4890. Epub 2016 Jun 22.
3
DT-13 suppresses breast cancer metastasis by modulating PLOD2 in the adipocytes microenvironment.DT-13 通过调节脂肪细胞微环境中的 PLOD2 抑制乳腺癌转移。
Phytomedicine. 2019 Jun;59:152778. doi: 10.1016/j.phymed.2018.12.001. Epub 2018 Dec 2.
4
The saponin monomer of dwarf lilyturf tuber, DT-13, inhibits angiogenesis under hypoxia and normoxia via multi-targeting activity.小百合块茎的皂苷单体 DT-13 通过多靶点活性抑制低氧和常氧条件下的血管生成。
Oncol Rep. 2013 Apr;29(4):1379-86. doi: 10.3892/or.2013.2272. Epub 2013 Feb 5.
5
Carcinoma associated fibroblasts (CAFs) promote breast cancer motility by suppressing mammalian Diaphanous-related formin-2 (mDia2).癌相关成纤维细胞(CAFs)通过抑制哺乳动物隔膜相关形态发生因子 2(mDia2)促进乳腺癌的迁移。
PLoS One. 2018 Mar 29;13(3):e0195278. doi: 10.1371/journal.pone.0195278. eCollection 2018.
6
The saponin monomer of dwarf lilyturf tuber, DT-13, reduces human breast cancer cell adhesion and migration during hypoxia via regulation of tissue factor.小根蒜甾体皂苷单体 DT-13 通过调控组织因子抑制低氧下人乳腺癌细胞黏附和迁移
Biol Pharm Bull. 2010;33(7):1192-8. doi: 10.1248/bpb.33.1192.
7
Metformin suppresses HIF-1α expression in cancer-associated fibroblasts to prevent tumor-stromal cross talk in breast cancer.二甲双胍通过抑制肿瘤相关成纤维细胞中 HIF-1α 的表达来防止乳腺癌中肿瘤-基质的相互作用。
FASEB J. 2020 Aug;34(8):10860-10870. doi: 10.1096/fj.202000951RR. Epub 2020 Jun 27.
8
DT-13, a saponin of dwarf lilyturf tuber, exhibits anti-cancer activity by down-regulating C-C chemokine receptor type 5 and vascular endothelial growth factor in MDA-MB-435 cells.DT-13,一种麦冬皂苷,通过下调MDA-MB-435细胞中的C-C趋化因子受体5型和血管内皮生长因子来发挥抗癌活性。
Chin J Nat Med. 2014 Jan;12(1):24-9. doi: 10.1016/S1875-5364(14)60005-4.
9
DT-13 attenuates human lung cancer metastasis via regulating NMIIA activity under hypoxia condition.DT-13通过在缺氧条件下调节肌球蛋白重链IIA(NMIIA)的活性来减弱人肺癌转移。
Oncol Rep. 2016 Aug;36(2):991-9. doi: 10.3892/or.2016.4879. Epub 2016 Jun 16.
10
Oroxylin A suppresses ACTN1 expression to inactivate cancer-associated fibroblasts and restrain breast cancer metastasis.山奈酚 A 通过抑制 ACTN1 的表达来抑制癌相关成纤维细胞并抑制乳腺癌转移。
Pharmacol Res. 2020 Sep;159:104981. doi: 10.1016/j.phrs.2020.104981. Epub 2020 May 31.

引用本文的文献

1
Unveiling the Antioxidant Role of Hemp Oils in Cancer Prevention and Treatment.揭示大麻油在癌症预防和治疗中的抗氧化作用。
Cancers (Basel). 2025 Jun 25;17(13):2128. doi: 10.3390/cancers17132128.
2
Development of clinically viable non-muscle myosin II small molecule inhibitors.具有临床可行性的非肌肉肌球蛋白II小分子抑制剂的研发。
Cell. 2025 Jun 27. doi: 10.1016/j.cell.2025.06.006.
3
Overexpression of miR-328-3p Inhibits Epithelial-Mesenchymal Transition in Prostate Cancer by Downregulating PFN1.miR-328-3p的过表达通过下调PFN1抑制前列腺癌的上皮-间质转化
Appl Biochem Biotechnol. 2025 Apr;197(4):2240-2257. doi: 10.1007/s12010-024-05103-1. Epub 2024 Dec 24.
4
Non-Muscle Myosin II A: Friend or Foe in Cancer?非肌肉肌球蛋白 IIA:癌症的朋友还是敌人?
Int J Mol Sci. 2024 Aug 30;25(17):9435. doi: 10.3390/ijms25179435.
5
Exploring the nexus between MYH9 and tumors: novel insights and new therapeutic opportunities.探索MYH9与肿瘤之间的联系:新见解与新治疗机遇。
Front Cell Dev Biol. 2024 Aug 1;12:1421763. doi: 10.3389/fcell.2024.1421763. eCollection 2024.
6
Establishment of Immune-related Gene Pair Signature to Predict Lung Adenocarcinoma Prognosis.建立免疫相关基因对特征以预测肺腺癌预后。
Cell Transplant. 2020 Jan-Dec;29:963689720977131. doi: 10.1177/0963689720977131.